...
Continue reading >>The stock market showed continued strength on Thursday and the start of the third-quarter with the broader market hitting a fresh record high. Better-than-expected economic news and the approval of a $715 billion transportation package fueled sentiment. Initial jobless claims posted another post-pandemic low after falling 51,000 to 364,000 versus forecasts for a print of 395,000. Meanwhile,...
Continue reading >>...
Continue reading >>The stock market rebounded on Wednesday with the small-caps leading the charge higher and the blue-chips struggling. Some of the strength came after a few Federal Reserve officials helped ease worries about higher inflation.A dip in bond yields continues to be positive for Technology as the 10-year Treasury note is pushing two-week lows. Key resistance levels remain in play with Wall Street...
Continue reading >>Oversold, OCGN is gaining momentum. According to Tip Ranks, “Ocugen has inked a deal with India-based Bharat Biotech for the US rights for the company’s vaccine COVAXIN. And Bharat has now reported positive second interim analysis results from the COVAXIN Phase 3 trials. The vaccine displayed an overall efficacy rate of 78%, with 100% success against severe cases of the disease. COVAXIN...
Continue reading >>The stock market rebounded on Wednesday with the small-caps leading the charge higher and the blue-chips struggling. Some of the strength came after a few Federal Reserve officials helped ease worries about higher inflation.A dip in bond yields continues to be positive for Technology as the 10-year Treasury note is pushing two-week lows. Key resistance levels remain in play with Wall Street...
Continue reading >>